Search

Search Results
Results 2001 - 2010 of 2867 for Bowel Cancer
  • Drug - 21 Jan 2026
    Consumer Medicine Information (CMI) about Remicade intended for persons living in Australia.
  • News - 20 Jan 2026
    Bowel habits aren't exactly dinner-table talk. But they reflect how quickly the gut moves things along, and when that goes wrong people can experience constipation, diarrhoea, or irritable bowel...
  • Drug - 16 Jan 2026
    Consumer Medicine Information (CMI) about Actemra intended for persons living in Australia.
  • Drug - 15 Jan 2026
    Consumer Medicine Information (CMI) about Xeljanz intended for persons living in Australia.
  • News - 6 Jan 2026
    Enveda, a multi-asset clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life’s chemistry, has announced that the US Food...
  • Drug - 15 Dec 2025
    Consumer Medicine Information (CMI) about DBL Bleomycin intended for persons living in Australia.
  • Drug - 11 Dec 2025
    Consumer Medicine Information (CMI) about DBL Oxaliplatin intended for persons living in Australia.
  • Drug - 8 Dec 2025
    Consumer Medicine Information (CMI) about DBL Heparin Sodium intended for persons living in Australia.
  • Drug - 8 Dec 2025
    Consumer Medicine Information (CMI) about Heparin Injection intended for persons living in Australia.
  • Drug - 13 Nov 2025
    Consumer Medicine Information (CMI) about Sutent intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.